We found that extracellular dsRNA and ZBP1-regulated neutrophil necroptosis could be potential targets for the treatment of these cell death-related diseases, including infectious diseases, cancer [40], neurological diseases [41], ischemic diseases and cardiovascular diseases [42]. Here, ZBP1 is linked to ischemic disease.